logo

Hikma Pharmaceuticals Plc (HIK.L)



Trade HIK.L now with
  Date
  Headline
3/31/2020 2:48:47 AM Hikma Pharma Announces Favourable Ruling In Generic Vascepa
3/31/2020 2:02:49 AM Hikma Confirms Favourable Ruling In Generic Vascepa Patent Suit
2/27/2020 2:15:18 AM Hikma Pharma Announces Signing Of US License Deal To Commercialise Ryaltris
2/27/2020 2:06:24 AM Hikma Pharma 2019 Group Core Revenue Of $2.203 Bln, Up 6%
2/27/2020 2:02:40 AM Hikma And Glenmark Sign Exclusive US License Agreement To Commercialise Ryaltris
1/13/2020 3:55:25 AM Hikma Pharma Announces Agreement With Chiesi Group
1/9/2020 3:02:20 AM Hikma And Arecor Enter Exclusive Agreement To Co-develop New, Ready-to-use Injectable Medicine In US
11/27/2019 2:06:12 AM Hikma Completes FDA Response For Generic Advair
11/7/2019 2:07:28 AM Hikma Pharma Still Sees Branded Revenue Growth In Cc In Mid-single Digits For FY
9/17/2019 4:03:34 AM Hikma Launches Prefilled Syringes In The US
8/9/2019 4:42:51 AM Hikma Pharma Inks Asset Purchase Agreement With Insys Therapeutics
8/9/2019 2:01:39 AM Hikma Pharma H1 Group Core Revenue Of $1.043 Bln, Up 7%
  
 
>